Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma-Reference-Cited by-同舟云学术

Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma

Published:2011-10-24 Issue:12 Volume:118 Page:3191-3198
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Price Tracy R.,Perkins Susan M.,Sandrasegaran Kumar,Henderson Mark A.,Maluccio Mary A.,Zook Jennifer E.,Tector A. Joseph,Vianna Rodrigo M.,Johnstone Peter A.S.,Cardenes Higinia R.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26404/fullpdf

Reference26 articles.

1. Estimating the world cancer burden: Globocan 2000;Parkin;Int J Cancer,2001

2. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. [Erratum appears in Ann Intern Med. 2004;140:151.] [Summary for patients in Ann Intern Med. 2003;139:I28; PMID: 14623640.];El-Serag;Ann Intern Med,2003

3. Management of hepatocellular carcinoma;Bruix;Hepatology,2005

4. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

5. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation;Llovet;Hepatology,1999

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Evolving Landscape of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma;Journal of Clinical and Experimental Hepatology;2025-01

2. Stereotactic body radiotherapy is an alternative to radiofrequency ablation for single HCC ≤5.0 cm;JHEP Reports;2024-10

3. Tumor Response on Diagnostic Imaging after Proton Beam Therapy for Hepatocellular Carcinoma;Cancers;2024-01-14

4. Prediction of SBRT response in liver cancer by combining original and delta cone-beam CT radiomics: a pilot study;Physical and Engineering Sciences in Medicine;2024-01-02

5. Imaging Assessment of Interventional Therapies in Lung and Liver;Interventional Oncology;2024